Prop-2-yn-1-yl-6-(2-(N-Acetylacetamido)pyridin-4-yl)-2-amino-4-(2-oxo-2-(prop-2-yn-1-yloxy)ethyl)-4H-chromene-3-carboxylate

ID: ALA4168985

PubChem CID: 145954627

Max Phase: Preclinical

Molecular Formula: C27H23N3O7

Molecular Weight: 501.50

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCOC(=O)CC1C(C(=O)OCC#C)=C(N)Oc2ccc(-c3ccnc(N(C(C)=O)C(C)=O)c3)cc21

Standard InChI:  InChI=1S/C27H23N3O7/c1-5-11-35-24(33)15-21-20-13-18(19-9-10-29-23(14-19)30(16(3)31)17(4)32)7-8-22(20)37-26(28)25(21)27(34)36-12-6-2/h1-2,7-10,13-14,21H,11-12,15,28H2,3-4H3

Standard InChI Key:  CWBRALMXCMJUPW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 39  0  0  0  0  0  0  0  0999 V2000
   39.3357  -27.3539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.3346  -28.1813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0494  -28.5941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7658  -28.1808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7630  -27.3503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0476  -26.9412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4810  -28.5922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4774  -29.4175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1916  -29.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1876  -28.1783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9024  -28.5858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9035  -29.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6156  -29.8218    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.3310  -29.4101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.3300  -28.5840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6134  -28.1696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.0455  -29.8226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   45.0443  -28.1712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.7589  -28.5835    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   45.0441  -27.3462    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   46.4733  -28.1708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.4730  -27.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.4727  -26.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6111  -27.3446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8956  -26.9340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8933  -26.1090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.1822  -27.3485    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.6067  -25.6946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.3223  -26.1052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.0378  -26.5158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6198  -28.5932    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.9057  -28.1801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1909  -28.5921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9063  -27.3551    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.6191  -29.4182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9044  -29.8301    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.3333  -29.8312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 12  2  0
 11 10  2  0
 10  7  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 14 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  3  0
 16 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  3  0
  2 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  2  0
 31 35  1  0
 35 36  2  0
 35 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4168985

    ---

Associated Targets(Human)

HL60/MX2 (68 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 501.50Molecular Weight (Monoisotopic): 501.1536AlogP: 2.04#Rotatable Bonds: 7
Polar Surface Area: 138.12Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.64CX LogP: 1.67CX LogD: 1.67
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.45Np Likeness Score: -0.38

References

1. Bian T, Chandagirikoppal Vijendra K, Wang Y, Meacham A, Hati S, Cogle CR, Sun H, Xing C..  (2018)  Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer Cells.,  61  (15): [PMID:29995404] [10.1021/acs.jmedchem.8b00813]

Source